Utility Menu French

National Association of Pharmacy Regulatory Authorities

Provinces French

Main navigation French


Recherchez dans la base de données des Annexes nationales de médicaments

Commencez votre recherche en utilisant le nom générique du produit :

Recherche par annexe
Réinitialiser

ATTENTION : Tous les résultats de la recherche seront tirés du « National Drug Schedules » du site Web en anglais.

Nom du médicament (en anglais) Commentaire Annexe Date
Zalcitabine or its saltsPDL I DEC / 13
Zaleplon or its salts or its derivativesPDL I NOV / 18
Zanamivir or its salts or derivativesPDL I DEC / 13
ZeranolC3 I SEP / 98
ZidovudinePDL I DEC / 13
Zinc chloride in injectable form for parenteral nutrition I JAN / 03
Zinc sulfate in injectable form for parenteral nutrition I JAN / 03
Ziprasidone or its saltsPDL I DEC / 13
Zoledronic acid or its salts or derivativesPDL I DEC / 13
Zolmitriptan or its saltsPDL I DEC / 13
Zolpidem and any salts thereofTS I JAN / 03
Zomepirac or its saltsPDL I DEC / 13
Zopiclone or its saltsPDL I DEC / 13
ZucapsaicinPDL I DEC / 13
Zuclopenthixol or its salts or derivativesPDL

Including but not limited to zuclopenthixol decanoate, zuclopenthixol hydrochloride.

I DEC / 13
a - MethylthiofentanylN I JUN / 02
alpha1- proteinase inhibitor (human) I JAN / 06
p-FluorofentanylN I JUN / 02

2018 résultats


Footnotes

  • C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
    N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
    NR - Drug has not been reviewed by the NDSAC
    PDL - Drug is listed in the Health Canada Prescription Drug List
    TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
    CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act